|
Volumn 39, Issue 4, 2009, Pages 266-267
|
Letters to the editors: Clinical-scientific notes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALLOPURINOL;
BENDROFLUMETHIAZIDE;
BEZAFIBRATE;
CABERGOLINE;
HYDROCORTISONE;
METFORMIN;
QUINAGOLIDE;
QUINAPRIL;
TESTOSTERONE;
THYROXINE;
DOPAMINE RECEPTOR STIMULATING AGENT;
ERGOLINE DERIVATIVE;
ADD ON THERAPY;
ADULT;
CASE REPORT;
CAUSE OF DEATH;
CEREBROVASCULAR ACCIDENT;
DRUG DOSE INCREASE;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
ECHOCARDIOGRAPHY;
HEART ATRIUM ENLARGEMENT;
HUMAN;
HYPOPITUITARISM;
INTESTINE OBSTRUCTION;
LETTER;
LOW DRUG DOSE;
MALE;
MITRAL VALVE REGURGITATION;
MITRAL VALVE REPLACEMENT;
PRIORITY JOURNAL;
PROLACTINOMA;
TRICUSPID ANNULOPLASTY;
TRICUSPID VALVE REGURGITATION;
VALVULAR HEART DISEASE;
BRAIN ISCHEMIA;
CHEMICALLY INDUCED DISORDER;
DOSE RESPONSE;
FATALITY;
FIBROSIS;
HEART LEFT VENTRICLE FUNCTION;
HEART VALVE REPLACEMENT;
HYPOPHYSIS TUMOR;
MIDDLE AGED;
PATHOLOGY;
BRAIN ISCHEMIA;
DOPAMINE AGONISTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ERGOLINES;
FATAL OUTCOME;
FIBROSIS;
HEART VALVE PROSTHESIS IMPLANTATION;
HUMANS;
INTESTINAL OBSTRUCTION;
MALE;
MIDDLE AGED;
MITRAL VALVE INSUFFICIENCY;
PITUITARY NEOPLASMS;
PROLACTINOMA;
TRICUSPID VALVE INSUFFICIENCY;
VENTRICULAR DYSFUNCTION, LEFT;
|
EID: 65349161494
PISSN: 14440903
EISSN: 14455994
Source Type: Journal
DOI: 10.1111/j.1445-5994.2009.01920.x Document Type: Letter |
Times cited : (22)
|
References (5)
|